Gene · 4200
Papers3,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. | J Biol Chem | 2023 | 37866632 | PubTator, text mining | PubMed |
| Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H2O2, and triggers early onset mitochondrial dysfunction during adipogenesis of human liposarcoma SW872 cells. | Redox Biol | 2023 | 37866162 | PubTator, text mining | PubMed |
| Overexpressing plant ferredoxin-like protein enhances photosynthetic efficiency and carbohydrates accumulation in Phalaenopsis. | Transgenic Res | 2023 | 37851307 | PubTator, text mining | PubMed |
| Taurine promotes muscle fiber type transformation through CaN/NFATc1 signaling in porcine myoblasts. | J Cell Physiol | 2023 | 37842836 | PubTator, text mining | PubMed |
| The mechanism of ferroptosis and its related diseases. | Mol Biomed | 2023 | 37840106 | PubTator, text mining | PubMed |
| Low RNA stability signifies strong expression regulatability of tumor suppressors. | Nucleic Acids Res | 2023 | 37831104 | PubTator, text mining | PubMed |
| Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. | Front Nutr | 2023 | 37818339 | PubTator, text mining | PubMed |
| Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide. | BMC Cancer | 2023 | 37803333 | PubTator, text mining | PubMed |
| Activation of the JNK/COX-2/HIF-1α axis promotes M1 macrophage via glycolytic shift in HIV-1 infection. | Life Sci Alliance | 2023 | 37798121 | PubTator, text mining | PubMed |
| Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM). | Front Endocrinol (Lausanne) | 2023 | 37795358 | PubTator, text mining | PubMed |
| Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations. | Front Cell Dev Biol | 2023 | 37779896 | PubTator, text mining | PubMed |
| Aspartic Acid in Health and Disease. | Nutrients | 2023 | 37764806 | PubTator, text mining | PubMed |
| Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals. | Cancers (Basel) | 2023 | 37760474 | PubTator, text mining | PubMed |
| A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity. | MedComm (2020) | 2023 | 37752942 | PubTator, text mining | PubMed |
| Cytotoxicity, acute and sub-chronic toxicities of the leaves of Bauhinia thonningii (Schumach.) Milne-Redh. (Caesalpiniaceae). | BMC Complement Med Ther | 2023 | 37752510 | PubTator, text mining | PubMed |
| Understanding COVID-19 progression with longitudinal peripheral blood mononuclear cell proteomics: Changes in the cellular proteome over time. | iScience | 2023 | 37736053 | PubTator, text mining | PubMed |
| A robust normalized local filter to estimate compositional heterogeneity directly from cryo-EM maps. | Nat Commun | 2023 | 37726277 | PubTator, text mining | PubMed |
| In vivo gene expression profile of Haemophilus influenzae during human pneumonia. | Microbiol Spectr | 2023 | 37707456 | PubTator, text mining | PubMed |
| Seminal biomarkers and their correlations to semen parameters in subfertile men. | Eur J Obstet Gynecol Reprod Biol X | 2023 | 37700886 | PubTator, text mining | PubMed |
| Redox state and altered pyruvate metabolism contribute to a dose-dependent metformin-induced lactate production of human myotubes. | Am J Physiol Cell Physiol | 2023 | 37694284 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4200/papers?page=10